Skip to main content
Addgene

pLenti6/V5-DEST-RINT1
(Plasmid #40124)

Print

Full plasmid sequence is not available for this item.

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 40124 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pLenti6-V5/DEST
  • Backbone manufacturer
    Invitrogen
  • Backbone size w/o insert (bp) 7732
  • Total vector size (bp) 10108
  • Vector type
    Mammalian Expression, Lentiviral
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    Stbl3
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    RINT1
  • Alt name
    RAD50 interactor 1
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    2376
  • Entrez Gene
    RINT1 (a.k.a. ILFS3, RINT-1)
  • Promoter CMV
  • Tag / Fusion Protein
    • V5 epitope (C terminal on backbone)

Cloning Information

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    The entry clone used to create this plasmid was obatined from the human ORFeome (v5.1) collection made available by the Center for Cancer Systems Biology at the Dana-Farber Cancer Institute in Boston, MA.

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pLenti6/V5-DEST-RINT1 was a gift from Lynda Chin (Addgene plasmid # 40124 ; http://n2t.net/addgene:40124 ; RRID:Addgene_40124)

  • For your References section:

    Integrative functional genomics identifies RINT1 as a novel GBM oncogene. Quayle SN, Chheda MG, Shukla SA, Wiedemeyer R, Tamayo P, Dewan RW, Zhuang L, Huang-Hobbs E, Haidar S, Xiao Y, Ligon KL, Hahn WC, Chin L. Neuro Oncol. 2012 Nov;14(11):1325-31. doi: 10.1093/neuonc/nos246. Epub 2012 Oct 16. 10.1093/neuonc/nos246 PubMed 23074196
Related items:
Commonly requested with: